Kewaunee Scientific (NASDAQ:KEQU) Shares Pass Above 200-Day Moving Average of $27.51

Shares of Kewaunee Scientific Co. (NASDAQ:KEQU) passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $27.51 and traded as high as $36.02. Kewaunee Scientific shares last traded at $34.80, with a volume of 4,348 shares.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the stock. TheStreet cut shares of Kewaunee Scientific from a “b-” rating to a “c” rating in a research report on Thursday, March 7th. StockNews.com upgraded Kewaunee Scientific from a “buy” rating to a “strong-buy” rating in a report on Thursday, March 14th.

Kewaunee Scientific Trading Down 2.5 %

The company has a market capitalization of $99.18 million, a PE ratio of 11.68 and a beta of 0.66. The stock’s 50 day moving average is $33.58 and its two-hundred day moving average is $27.51. The company has a quick ratio of 1.76, a current ratio of 2.28 and a debt-to-equity ratio of 0.61.

Kewaunee Scientific (NASDAQ:KEQU) last announced its quarterly earnings results on Wednesday, March 6th. The technology company reported $0.85 earnings per share (EPS) for the quarter. The business had revenue of $46.78 million for the quarter. Kewaunee Scientific had a return on equity of 20.82% and a net margin of 4.34%.

Insiders Place Their Bets

In other news, VP Douglas J. Batdorff sold 3,500 shares of Kewaunee Scientific stock in a transaction that occurred on Friday, March 15th. The shares were sold at an average price of $31.35, for a total value of $109,725.00. Following the transaction, the vice president now owns 6,167 shares of the company’s stock, valued at approximately $193,335.45. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In other news, VP Elizabeth D. Phillips sold 3,277 shares of the company’s stock in a transaction dated Tuesday, March 26th. The shares were sold at an average price of $32.50, for a total transaction of $106,502.50. Following the transaction, the vice president now owns 10,263 shares in the company, valued at $333,547.50. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, VP Douglas J. Batdorff sold 3,500 shares of Kewaunee Scientific stock in a transaction that occurred on Friday, March 15th. The stock was sold at an average price of $31.35, for a total transaction of $109,725.00. Following the completion of the sale, the vice president now owns 6,167 shares of the company’s stock, valued at $193,335.45. The disclosure for this sale can be found here. 14.50% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Kewaunee Scientific stock. Minerva Advisors LLC lifted its position in Kewaunee Scientific Co. (NASDAQ:KEQU) by 0.9% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 174,432 shares of the technology company’s stock after acquiring an additional 1,513 shares during the period. Kewaunee Scientific accounts for approximately 2.0% of Minerva Advisors LLC’s investment portfolio, making the stock its 17th biggest holding. Minerva Advisors LLC owned about 6.01% of Kewaunee Scientific worth $2,843,000 at the end of the most recent reporting period. 32.69% of the stock is owned by institutional investors.

About Kewaunee Scientific

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.